Valley Brook Capital Group’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$255K Buy
2,325
+75
+3% +$10.7K 0.17% 98
2025
Q4
$374K Buy
2,250
+780
+53% +$130K 0.25% 80
2025
Q3
$288K Buy
+1,470
New +$242K 0.19% 92

Other funds holding ALAB

Valley Brook Capital Group's ALAB Position: Q1 2026 in Review

Valley Brook Capital Group increased its Astera Labs (ALAB) stake by 3.3% in Q1 2026, buying an estimated $10.7K and bringing the position to 2,325 shares worth $255K. The position accounts for 0.17% of the portfolio, ranked #98.

Valley Brook Capital Group first reported a position in ALAB in Q3 2025 and has held it in 3 quarters since. The position peaked at $374K in Q4 2025. 703 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

  • Valley Brook Capital Group held 2,325 shares of Astera Labs worth $255K as of Q1 2026.
  • Valley Brook Capital Group bought 75 Astera Labs shares in Q1 2026, an estimated $10.7K.
  • Astera Labs made up 0.17% of Valley Brook Capital Group's portfolio in Q1 2026, its #98 holding.
  • Valley Brook Capital Group first reported a position in Astera Labs in Q3 2025 and has held it in 3 quarters since.
  • Valley Brook Capital Group's Astera Labs position peaked at $374K in Q4 2025.
  • 703 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on Valley Brook Capital Group's 13F filing for Q1 2026, filed 8 May 2026.